Unconventional SCCmec types and low prevalence of the Panton-Valentine Leukocidin exotoxin in South African blood culture Staphylococcus aureus surveillance isolates, 2013-2016.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 21 08 2019
accepted: 11 11 2019
entrez: 28 11 2019
pubmed: 28 11 2019
medline: 26 3 2020
Statut: epublish

Résumé

Staphylococcus aureus is a healthcare-associated pathogen that can harbour multiple antimicrobial resistance determinants and express multiple virulence factors e.g. Panton-Valentine Leukocidin (PVL). Unknown staphylococcal cassette chromosome mec (SCCmec) typing patterns were previously observed among 11% (n = 52) of methicillin-resistant S. aureus (MRSA) isolates; we further investigated these as well as the proportion of PVL, encoded by lukS/F-PV, in 761 S. aureus isolates from patients with a diagnosis of pneumonia/lower respiratory tract, skin/soft tissue, bone and joint infection. S. aureus isolates from blood culture were identified and antimicrobial susceptibility testing was performed using automated systems. Conventional PCR assays were used to identify the ccr and mec gene complexes in mecA-positive isolates with an unknown SCCmec type and screen for lukS/F-PV. Epidemiological data was used to classify isolates as healthcare- or community-associated infections. Antimicrobial susceptibility profiles according to SCCmec type and PVL were reported. Of the unknown SCCmec types, isolates were interpreted as type I-like (86%, 38/44), type II-like (9%, 4/44) and type III-like (5%, 2/44). Eight isolates did not produce definitive results. Of all MRSA isolates, majority were multidrug-resistant as indicated by their non-susceptibility to most antimicrobial agents; 92% were healthcare-associated. PVL was seen in 14% of the isolates (MRSA: 25%, MSSA: 75%); 56% were classified as healthcare-associated infection. The SCCmec typing method did not definitively classify all unknown isolates into clearly defined types. It showed that majority of these isolates were not the conventional types; untypeable elements appeared to be composite SCCmec elements, consisting of multiple ccr gene complexes. Majority of the MRSA isolates were non-susceptible to most antibiotics indicating that multiple resistance genes are present in our population. Furthermore, the proportion of PVL was low and more prevalent in MSSA.

Identifiants

pubmed: 31774877
doi: 10.1371/journal.pone.0225726
pii: PONE-D-19-23434
pmc: PMC6881059
doi:

Substances chimiques

Bacterial Toxins 0
Exotoxins 0
Leukocidins 0
Panton-Valentine leukocidin 0
Virulence Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0225726

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Clin Microbiol. 2010 Apr;48(4):1384-90
pubmed: 20129971
Mikrobiyol Bul. 2012 Jul;46(3):341-51
pubmed: 22951646
Int J Med Microbiol. 2014 Oct;304(7):794-804
pubmed: 25034857
Antimicrob Agents Chemother. 2009 Dec;53(12):4961-7
pubmed: 19721075
Int J Med Microbiol. 2013 Aug;303(6-7):350-9
pubmed: 23499303
Antimicrob Agents Chemother. 2012 Oct;56(10):4997-9
pubmed: 22869575
JAAD Case Rep. 2016 Dec 04;2(6):428-429
pubmed: 27957522
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Clin Microbiol Infect. 2005 Jun;11(6):447-56
pubmed: 15882194
J Clin Microbiol. 2010 Mar;48(3):720-7
pubmed: 20042625
Int J Antimicrob Agents. 2018 Jan;51(1):16-25
pubmed: 29174420
Pol J Microbiol. 2011;60(2):95-103
pubmed: 21905625
Antimicrob Agents Chemother. 2007 Sep;51(9):3374-7
pubmed: 17576837
J Infect Dis. 2008 May 1;197(9):1235-43
pubmed: 18422435
PLoS One. 2015 Dec 31;10(12):e0145429
pubmed: 26719975
J Clin Microbiol. 2009 Mar;47(3):590-5
pubmed: 19144813
Infect Genet Evol. 2018 Jul;61:74-76
pubmed: 29567305
J Med Microbiol. 2009 Sep;58(Pt 9):1213-8
pubmed: 19528158
J Glob Antimicrob Resist. 2016 Sep;6:95-101
pubmed: 27530849
Acta Microbiol Immunol Hung. 2013 Sep;60(3):261-70
pubmed: 24060551
Eur J Clin Microbiol Infect Dis. 2017 Dec;36(12):2519-2532
pubmed: 28849285
J Clin Microbiol. 2007 Mar;45(3):1019-21
pubmed: 17192420
Antimicrob Agents Chemother. 2015 Dec;59(12):7597-601
pubmed: 26416872
Braz J Infect Dis. 2017 Jul - Aug;21(4):464-467
pubmed: 28482183
Antimicrob Agents Chemother. 2007 Jan;51(1):264-74
pubmed: 17043114
Clin Infect Dis. 2014 Mar;58(5):609-18
pubmed: 24336829
J Clin Microbiol. 2011 Aug;49(8):3071-3
pubmed: 21697325

Auteurs

Ashika Singh-Moodley (A)

Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses, National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa.
Department of Clinical Microbiology and Infectious Diseases, School of Pathology, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.

Wilhelmina Strasheim (W)

Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses, National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa.

Ruth Mogokotleng (R)

Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses, National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa.

Husna Ismail (H)

Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses, National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa.

Olga Perovic (O)

Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses, National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa.
Department of Clinical Microbiology and Infectious Diseases, School of Pathology, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH